Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Buy

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Zai Lab Limited American Depositary Shares (ZLAB)

Pharmaceutical Preparations

https://www.zailaboratory.com

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatment across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

4560 JINKE ROAD, BLDG. 1, 4F, PUDONG
SHANGHAI, F4

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/20/2017

Market Cap

1,684,998,860

Shares Outstanding

992,090,000

Weighted SO

98,719,430

Total Employees

N/A

Upcoming Earnings

08/06/2024

Similar Tickers

CCCC --.--%

ERAS --.--%

CGEM --.--%

LEGN --.--%

SGEN --.--%

ALNY --.--%

ASND --.--%

ROIV --.--%

Beta

1.0530

Last Div

0.0000

Range

13.48-31.22

Chg

0.3500

Avg Vol

558504

Mkt Cap

1684998860

Exch

NASDAQ

Country

CN

Phone

86 21 6163 2588

DCF Diff

2.4131

DCF

47.2931

Div Yield

0.0000

P/S

5.2214

EV Multiple

-3.2221

P/FV

2.3561

Div Yield %

0.0000

P/E

-5.5613

PEG

-0.1782

Payout

0.0000

Current Ratio

3.4559

Quick Ratio

3.2897

Cash Ratio

2.9003

DSO

87.9239

DIO

127.7415

Op Cycle

215.6653

DPO

388.7375

CCC

-173.0721

Gross Margin

0.6295

Op Margin

-1.0967

Pretax Margin

-0.9244

Net Margin

-0.9244

Eff Tax Rate

-0.0397

ROA

-0.3021

ROE

-0.3796

ROCE

-0.4811

NI/EBT

1.0000

EBT/EBIT

0.8429

EBIT/Rev

-1.0967

Debt Ratio

0.0848

D/E

0.1188

LT Debt/Cap

0.0082

Total Debt/Cap

0.1062

Int Coverage

-17.6971

CF/Debt

-2.4195

Equity Multi

1.4022

Rec Turnover

4.1513

Pay Turnover

0.9389

Inv Turnover

2.8573

FA Turnover

5.0613

Asset Turnover

0.3268

OCF/Share

-2.0746

FCF/Share

-2.2438

Cash/Share

7.4805

OCF/Sales

-0.6274

FCF/OCF

1.0815

CF Coverage

-2.4195

ST Coverage

-2.5998

CapEx Coverage

-12.2634

Div&CapEx Cov

-12.2634

P/BV

2.3561

P/B

2.3561

P/S

5.2214

P/E

-5.5613

P/FCF

-7.6948

P/OCF

-8.1944

P/CF

-8.1944

PEG

-0.1782

P/S

5.2214

EV Multiple

-3.2221

P/FV

2.3561

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 16, 04:32 argenx and Zai Lab Announce Approval of Efgartigimod Alfa - GlobeNewswire GlobeNewswire Inc. Oct 26, 07:30 Zai Lab Announces Participation in November Investor Conferences

Revenue Product Segmentation